Palestine Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palestine Health Report.

Press releases published on July 8, 2026

7 hours ago

Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval

Indeterminate GlobeNewswire

7 hours ago

On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper

Indeterminate GlobeNewswire

7 hours ago

Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors

Indeterminate GlobeNewswire

8 hours ago

Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness

Indeterminate GlobeNewswire

10 hours ago

LincNutri Launches NAD+ Supplement for Women, Expanding Its Healthy Aging Portfolio with Multi-Ingredient Cellular Support

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical Mengadakan Perjanjian dengan Novo Nordisk untuk Mengevaluasi NPM-139, Implan Semaglutide Miniatur dengan Kerja Sangat Panjang untuk Pengelolaan Berat Badan Kronis

Indeterminate GlobeNewswire

10 hours ago

ヴィヴァニ・メディカル、慢性体重管理のためのセマグルチドの超長時間作用小型インプラント「NPM-139」の評価に向け、ノボ ノルディスクと契約を締結

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical, 만성 체중관리용 초장기 지속형 세마글루타이드 임플란트 'NPM-139' 평가 위해 Novo Nordisk와 계약 체결

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical Menandatangani Perjanjian dengan Novo Nordisk bagi Menilai NPM-139, Implan Semaglutide Miniatur dengan Tindakan Ultra Jangka Panjang bagi Pengurusan Berat Badan Kronik

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical เข้าทำข้อตกลงกับ Novo Nordisk เพื่อประเมิน NPM-139…

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139

Indeterminate GlobeNewswire

10 hours ago

Vivani Medical 與 Novo Nordisk 達成協議，評估一種微型、超長效並用於慢性體重管理的司美格魯肽植入劑 NPM-139

Indeterminate GlobeNewswire

11 hours ago

Alamar Biosciences 推出首个针对 eMTBR-Tau 的多重血液免疫检测，后者是阿尔茨海默病研究中最重要的生物标志物之一

Indeterminate GlobeNewswire

11 hours ago

Alamar Biosciences 推出首款血液多重免疫檢測，用於檢測 eMTBR-Tau，它是阿茲海默症研究中最重要生物標記之一

Indeterminate GlobeNewswire

12 hours ago

Trimoryn Supplement Facts Analysis: Latest Safety Report Issued to Consumers About Ingredients' Effectiveness & Side Effects Risk

Indeterminate GlobeNewswire

13 hours ago

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire